𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Systematic review and meta-analysis: Anti–tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis

✍ Scribed by Cheryl Barnabe; Billie-Jean Martin; William A. Ghali

Publisher
Wiley (John Wiley & Sons)
Year
2011
Tongue
English
Weight
176 KB
Volume
63
Category
Article
ISSN
2151-464X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-tumor necrosis factor α switching i
Anti-tumor necrosis factor α switching in rheumatoid arthritis and juvenile chronic arthritis
✍ Favalli, Ennio Giulio ;Arreghini, Marco ;Arnoldi, Cristina ;Panni, Benedetta ;Ma 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 1 views

COPD ϭ chronic obstructive pulmonary disease. 300 Letters \* RA ϭ rheumatoid arthritis; JRA ϭ juvenile rheumatoid arthritis; ESR ϭ erythrocyte sedimentation rate; CRP ϭ C-reactive protein; VAS ϭ visual analog scale; GH ϭ general health; DAS28 ϭ Disease Activity Score in 28 joints; HAQ ϭ Health Asses

Anti–tumor necrosis factor α therapy and
Anti–tumor necrosis factor α therapy and the risk of lymphoma in rheumatoid arthritis: No clear answer
✍ Deborah P. M. Symmons; Alan J. Silman 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 50 KB 👁 1 views

The authors are the principal investigators of the British Society of Rheumatology (BSR) Biologics Register. The BSR receives financial support for the Register from the manufacturers of biologic agents currently licensed for use in the treatment of patients with inflammatory rheumatic diseases. The

Anti–tumor necrosis factor therapy incre
Anti–tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis
✍ Anca Irinel Catrina; Erik af Klint; Sofia Ernestam; Sergiu-Bogdan Catrina; Dimit 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB 👁 2 views

## Abstract ## Objective Treatment of rheumatoid arthritis (RA) with tumor necrosis factor (TNF)–blocking agents, including etanercept and infliximab, has resulted in reductions in the radiographic progression of RA. However, the exact mechanism by which this protection occurs has not been determi